General Information of Drug (ID: DM7AJER)

Drug Name
PMID25719566C1 Drug Info
Synonyms GTPL8302; MolPort-016-611-562; ZINC65410133; BDBM50078632; MCULE-6970562839; 43C
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
50967109
TTD Drug ID
DM7AJER

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
BAZ2-ICR DMKDZLG Discovery agent N.A. Investigative [1]
GSK2801 DMDSK9N Discovery agent N.A. Investigative [2]
PMID25719566C7 DMGCAIO Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Bromodomain adjacent to zinc finger 2B (BAZ2B) TT6K8YG BAZ2B_HUMAN Inhibitor [1]

References

1 Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B. J Med Chem. 2015 Mar 12;58(5):2553-9.
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2722).